Sanbo Hospital Management Group Limited (SHE:301293)
China · Delayed Price · Currency is CNY 75.87
-1.03 (-1.34%)
Feb 11, 2026, 4:00 PM EST
SHE:301293 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,633 | 1,419 | 1,305 | 1,064 | 1,132 | 983.38 |
Other Revenue | 10.6 | 10.6 | 8.39 | 5.97 | 4.82 | 3.77 |
| 1,644 | 1,429 | 1,313 | 1,070 | 1,137 | 987.15 | |
Revenue Growth (YoY) | 16.75% | 8.84% | 22.73% | -5.90% | 15.20% | -3.13% |
Cost of Revenue | 1,258 | 1,096 | 1,020 | 838.33 | 863.59 | 751.26 |
Gross Profit | 385.61 | 333.27 | 293.18 | 231.76 | 273.63 | 235.89 |
Selling, General & Admin | 235.88 | 191.94 | 162.4 | 140.89 | 151.79 | 131.33 |
Other Operating Expenses | 5.28 | 1.34 | 0.6 | 0.1 | -0.02 | 0.33 |
Operating Expenses | 240.38 | 193.51 | 164.38 | 140.01 | 152.32 | 132.49 |
Operating Income | 145.23 | 139.76 | 128.8 | 91.75 | 121.3 | 103.4 |
Interest Expense | -12.25 | -7.85 | -9.69 | -11.69 | -11.56 | -1.18 |
Interest & Investment Income | 5.4 | 11.48 | 15.71 | 7.19 | 3.71 | 4.18 |
Other Non Operating Income (Expenses) | -11.31 | -1.15 | -1.04 | -1.85 | -2.99 | -1.13 |
EBT Excluding Unusual Items | 127.07 | 142.24 | 133.78 | 85.4 | 110.47 | 105.27 |
Gain (Loss) on Sale of Investments | 1.65 | 9.06 | 5.34 | 4.12 | 7.41 | 14.04 |
Gain (Loss) on Sale of Assets | 1.27 | 0.05 | 0.05 | 0.22 | 0.1 | 0.01 |
Asset Writedown | -1.42 | -1.22 | -0.44 | -0.26 | -0.59 | -1.35 |
Legal Settlements | - | - | - | - | -4.64 | -4.28 |
Other Unusual Items | -4.87 | 1.26 | -20.43 | 9.82 | 1.43 | -18.96 |
Pretax Income | 123.7 | 151.39 | 118.3 | 99.29 | 114.18 | 94.73 |
Income Tax Expense | 45.15 | 35.81 | 33.77 | 21.92 | 26.8 | 20.65 |
Earnings From Continuing Operations | 78.54 | 115.58 | 84.53 | 77.37 | 87.38 | 74.08 |
Minority Interest in Earnings | 5.56 | -10.55 | -6.29 | -13.92 | -10.68 | -12.34 |
Net Income | 84.11 | 105.03 | 78.24 | 63.45 | 76.69 | 61.74 |
Net Income to Common | 84.11 | 105.03 | 78.24 | 63.45 | 76.69 | 61.74 |
Net Income Growth | -23.29% | 34.24% | 23.31% | -17.27% | 24.22% | 21.41% |
Shares Outstanding (Basic) | 205 | 206 | 191 | 156 | 154 | 151 |
Shares Outstanding (Diluted) | 205 | 206 | 191 | 156 | 154 | 151 |
Shares Change (YoY) | -2.66% | 7.92% | 22.62% | 0.73% | 2.59% | 7.57% |
EPS (Basic) | 0.41 | 0.51 | 0.41 | 0.41 | 0.50 | 0.41 |
EPS (Diluted) | 0.41 | 0.51 | 0.41 | 0.41 | 0.50 | 0.41 |
EPS Growth | -21.20% | 24.39% | 0.56% | -17.87% | 21.77% | 12.78% |
Free Cash Flow | -549.55 | -379.88 | 76 | 62.95 | -23.07 | -336.18 |
Free Cash Flow Per Share | -2.68 | -1.84 | 0.40 | 0.41 | -0.15 | -2.23 |
Dividend Per Share | 0.148 | 0.148 | 0.073 | - | - | - |
Dividend Growth | 102.46% | 102.46% | - | - | - | - |
Gross Margin | 23.46% | 23.32% | 22.32% | 21.66% | 24.06% | 23.90% |
Operating Margin | 8.83% | 9.78% | 9.81% | 8.57% | 10.67% | 10.47% |
Profit Margin | 5.12% | 7.35% | 5.96% | 5.93% | 6.74% | 6.25% |
Free Cash Flow Margin | -33.43% | -26.58% | 5.79% | 5.88% | -2.03% | -34.06% |
EBITDA | 187.98 | 182.72 | 172.05 | 139.87 | 165.24 | 133.2 |
EBITDA Margin | 11.43% | 12.78% | 13.10% | 13.07% | 14.53% | 13.49% |
D&A For EBITDA | 42.75 | 42.97 | 43.25 | 48.13 | 43.94 | 29.8 |
EBIT | 145.23 | 139.76 | 128.8 | 91.75 | 121.3 | 103.4 |
EBIT Margin | 8.83% | 9.78% | 9.81% | 8.57% | 10.67% | 10.47% |
Effective Tax Rate | 36.50% | 23.65% | 28.55% | 22.07% | 23.47% | 21.80% |
Revenue as Reported | 1,644 | 1,429 | 1,313 | 1,070 | 1,137 | 987.15 |
Advertising Expenses | - | 12.16 | 3.25 | 0.89 | 0.82 | 0.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.